CD274 and neoplasm: Additionally, these cells upregulate antioxidant molecules such as PD-L1 and inhibit lipid peroxidation damage, thereby reducing tumor cell sensitivity to ferroptosis inducers such as Erastin and RSL3, further contributing to therapeutic resistance (42).